Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian ...

Outcomes are compared with 6-month outcomes after anterior 180° partial fundoplication, and sham procedures from trials of endoscopic therapies. No sham-controlled trial of EsophyX TIF procedure ...

R 31 000 000 Farm Cato Ridge Prime opportunity to acquire this magnificent 37.5-hectare farm. This spectacular property is on a gentle slope with over 30 hectares ... 37.563 ha R 450 000 Vacant Land ...